Given the relevance of this pathway in cancer biology, future studies should consider including PI3K/AKT/mTOR alterations to provide a more comprehensive understanding of the molecular mechanisms driving EOCRC, particularly among ethnic populations such as H/L patients. The gene discussed is AKT1; the disease is cancer.